[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
November 28, 2001

Can a Common Medical Practice Transform Candida Infections From Benign to Deadly?

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;286(20):2531-2532. doi:10.1001/jama.286.20.2531

San Francisco—New research hints that a common medical practice—the use of heparin in intravascular catheters to discourage blockages by blood clots—may sometimes inadvertently trigger events that transform a benign fungal infection into a deadly illness.

The microbe in question is Candida albicans, a yeast that often harmlessly colonizes patients. But C albicans has a darker side: it is also the leading cause of invasive fungal disease in premature infants and others with weakened immune systems, such as individuals infected with HIV, people recovering from surgery, and cancer or bone marrow transplantation patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×